PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Blue Shield of CaliforniaAll Plans · Coverage · Medical Policy · CA · Gastroenterology, RadiologyMedium impact

Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease (2.04.41)

Effective date
Jan 1, 2026
Identified
Nov 1, 2025

Summary

Blue Shield of California medical policy 2.04.41 covers noninvasive tests for evaluating and monitoring chronic liver disease. The FibroSURE multianalyte assay and transient elastography (FibroScan) may be considered medically necessary for evaluation of individuals with chronic liver disease, and both are considered investigational for monitoring. Other multianalyte assays with algorithmic analyses, and other noninvasive imaging including magnetic resonance elastography, multiparametric MRI, acoustic radiation force impulse imaging, and real-time tissue elastography, are considered investigational for evaluation or monitoring. The policy was updated on 01/01/2026 with a revised policy statement, guidelines and literature review.

Get alerts when payers change rules like this one

We check Blue Shield of California and other payers every day and email you when a change matches your specialty and state.

Get Blue Shield of California alertsPolicy Monitoring is free. No card required.

What to do

Action · 4 steps
01Already effective 2026-01-01: Include the documentation this policy requests for these tests.
02Before the test, provide the history and physical and/or consultation notes, including the specific name of the test requested, the reason for testing (whether it is for initial evaluation or ongoing monitoring), and previous pertinent laboratory test results.
03After the test, include the results or reports of the tests performed.
04Monitoring with FibroSURE or transient elastography is considered investigational under this policy.

Codes mentioned

7639176981769827698381517815968388391200

Original notice

Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease (2.04.41)
blueshieldca.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account